CONNECT WITH US
HealthTech

HealthTech

Ochsner’s Trainor Says ChatGPT Health Is Forcing a Patient AI Decision

HealthSystemCIO logo

Published on

Add as a preferred source on Google
Ochsner’s Trainor Says ChatGPT Health Is Forcing a Patient AI Decision

Ochsner Health CIO Amy Trainor explains why patients linking their charts to ChatGPT have Ochsner weighing a wider rollout of Epic’s Emmie. Watch below or on YouTube.

About 4,500 Ochsner Health patients had connected their medical records to ChatGPT by the end of September. As a result, Ochsner faces a short window to decide whether to expand its own patient-facing AI or cede more of those patient interactions to ChatGPT. Amy Trainor, RN, SVP and chief information officer at Ochsner Health, said Sept. 30 that the decision would come within roughly two months. She spoke on a recent episode of the healthsystemCIO Show. In fact, Ochsner already runs Emmie, Epic’s AI assistant for patients in MyChart, for a small group of patients. The open question is whether to scale it.

When OpenAI introduced ChatGPT Health in January, it reported more than 230 million people worldwide asking health and wellness questions each week. By July, OpenAI had raised that figure to more than 300 million. Trainor applied the January number to Louisiana and arrived at about 1.1 million people a week, which by her estimate is roughly 25% of the state’s population. She also said about 4,500 Ochsner patients had connected their charts to ChatGPT by Sept. 30.

Other health systems saw the shift from the infrastructure side. Matthew Kull, EVP and chief information and digital officer at Inova Health, told healthsystemCIO in September that API calls from ChatGPT into Inova’s Epic environment had climbed sharply. The jump followed the launch of the record connection.


Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.